Product Information

ATORVASTATIN 40 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0370 per EA under NDC 68382025110. Its NADAC has been published 400 times since Dec 26, 2018.

FDA first approved this application on Nov 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATORVASTATIN 40 MG TABLET

atorvastatin calcium
$0.0370per EA
Discontinued

Strength

40 mg/1

NDC

68382025110

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206536

FDA Approved

11/20/2018

TE Code

AB

On Market Since

11/21/2018

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 40 MG TABLET has been published 400 times since Dec 26, 2018, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0370 per EA
All-time high$0.1103 (Jun 12, 2019)
All-time low$0.0370 (Aug 19, 2026)
52-week high$0.0449
52-week low$0.0370
Median price$0.0608
Average price$0.0648
Largest weekly change+27.7% (Aug 21, 2024)
Weeks tracked400
Tracking sinceDec 26, 2018

Price History

1W

-0.9%

1M

-2.2%

3M

-3.1%

6M

-8.1%

1Y

-17.5%

3Y

-35.4%

5Y

-41.0%

All

-64.0%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0370 per EA (NDC 68382025110), effective Aug 19, 2026.

How has the price of ATORVASTATIN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 64.0%. It has been tracked across 400 weekly CMS publications since Dec 26, 2018.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?

Since Dec 26, 2018, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0370 (Aug 19, 2026) to a high of $0.1103 (Jun 12, 2019), with a median of $0.0608 per EA.

Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ATORVASTATIN 40 MG TABLET?

ATORVASTATIN 40 MG TABLET (NDC 68382025110) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.